Agsalda-Garcia, Melissa

Connection

Melissa Agsalda-Garcia to Dose-Response Relationship, Drug

Back to Details

This is a "connection" page, showing publications Melissa Agsalda-Garcia has written about Dose-Response Relationship, Drug.

Melissa Agsalda-Garcia

Connection Strength

0.039

Dose-Response Relationship, Drug

Goldman S, Barth M, Shiramizu B, Shi Q, Hochberg J, Klejmont L, Harrison L, Basso J, Chu Y, Islam H, Gerard P, Agsalda-Garcia M, Shieh T, Oesterheld J, Heym K, Kirov I, Drachtman R, Harker-Murray P, Perkins S, Miles RR, Cairo M. A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma. Leukemia. 2021 10; 35(10):2994-2997.
View in: PubMed

Score: 0.039

Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support